|
Post by jonny80s on Jan 24, 2019 10:58:43 GMT -5
Anyone else think the estimate of $5.2m for 4q is ridiculously low? They are factoring a 25% increase in scripts. But the script increase was significantly higher. Plus, sales volume were higher due to increase in cartridge per script.
Even with discounts we should be in $10mil range and $15mil without.
|
|
|
Post by mannmade on Jan 24, 2019 11:06:22 GMT -5
Well this is a pure guesstimate but if you take an estimated net revenue average of say $475k x 12 weeks you get $5.7m so that would be my guess and seems reasonable on their end from my POV.
|
|
|
Post by jonny80s on Jan 24, 2019 11:34:21 GMT -5
Yes I agree with revenue estimate, but they estimated the 5.2 for sales not revenue.
|
|
|
Post by mannmade on Jan 24, 2019 11:42:19 GMT -5
If I understand you correctly then they are wrong or made a mistake in wording.
|
|
|
Post by cjm18 on Jan 24, 2019 12:44:43 GMT -5
3rd quarter sales were 4.4m net. (8.2m gross).
|
|
|
Post by Thundersnow on Jan 24, 2019 12:45:59 GMT -5
Anyone else think the estimate of $5.2m for 4q is ridiculously low? They are factoring a 25% increase in scripts. But the script increase was significantly higher. Plus, sales volume were higher due to increase in cartridge per script. Even with discounts we should be in $10mil range and $15mil without. GARBAGE IN.......GARBAGE OUT
|
|
|
Post by casualinvestor on Jan 25, 2019 14:53:03 GMT -5
Symphony sales 2018 Q3: $9.93M Symphony sales 2018 Q4: $11.5M
That's about a 16% increase in symphony sales Q-over-Q. Giving us 25% is pretty generous. Do they know something we don't regarding direct sales?
Q3 net was $4.4M, so if the ratio's hold, then we would expect ~$5.1M for Q4. You can't factor in an increase in cartridges/script if you are looking at $$$ growth. That's already included with the $$$
Sorry if I'm getting in the way of a good rant
|
|